As part of his recent trip to China, Prof Veron Ramsuran visited GenePlus Technology in Beijing, where advances in modern medicine are taking shape at the intersection of genomics, technology and precision medicine.

GenePlus is contributing to this rapidly evolving field through its work in genetic testing, next-generation sequencing and precision medicine, translating genomic science into applications that can improve how disease is understood, detected and managed. The company is a biotechnology and precision medicine business with expertise spanning genomic sequencing, genetic testing, molecular diagnostics and precision oncology, and its work highlights the growing role of large-scale genomic technologies in advancing more personalised approaches to healthcare, in which an individual’s genetic information can support more informed disease prevention, diagnosis and treatment.

During the visit, Prof Ramsuran engaged with scientists and researchers working at the forefront of genomic technologies. The discussions provided an opportunity to exchange perspectives, explore shared research interests and gain insight into the technologies shaping the future of genomics.

For Prof Ramsuran, the visit created a valuable link between research in Africa and technological advances in China. These shared scientific interests present opportunities for knowledge exchange and collaborative research, particularly as African researchers work to ensure that African populations are better represented in global genomic studies.